Company profile: Tissue Solutions
1.1 - Company Overview
Company description
- Provider of rapid, ethically compliant access to high-quality biospecimens via a virtual biobank offering a single point of access to diseased and normal human biomaterials.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tissue Solutions
PathogenDx
HQ: United States
Website
- Description: Provider of RT-PCR and DNA microarray-based pathogen detection solutions, including assays for SARS-CoV-2 genes and variants (DetectX-Rv, DetectX-Cv), environmental SARS-CoV-2 screening (EnviroX-Rv), a UTI panel detecting 26 pathogens and 12 antibiotic resistance markers (D3 Array-UTI), and semi-quantitative fungal and bacterial assays (QuantX Fungal, QuantX Bacterial).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PathogenDx company profile →
Beacon Discovery
HQ: United States
Website
- Description: Provider of GPCR-focused drug discovery services from concept to clinic, including over 8,000 assays, target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity. Offerings include small molecule support, LeadHunter cell-based assays for GPCRs and orphan GPCRs, phenotypic drug discovery, in vitro safety assays and panels, and ADME assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beacon Discovery company profile →
Alamar Biosciences
HQ: United States
Website
- Description: Provider of technologies enabling the earliest possible detection and treatment of cancer and other diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alamar Biosciences company profile →
Alsachim
HQ: France
Website
- Description: Provider of contract research and development services to customers around the world, stable isotope-labeled compounds for pharmaceuticals, environmental studies, and clinical diagnostics, and labeled internal and reference standards for LC-MS/MS analysis to ensure accurate quantification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alsachim company profile →
Nanna Therapeutics
HQ: United Kingdom
Website
- Description: Provider of drug discovery platforms targeting fundamental cellular processes in age-related diseases. Offers the Nanoscale Medicines Discovery Engine for novel drugs addressing mitochondrial dysfunction and the Totally Integrated Medicines Engine (TIME), conducting 100 million phenotypic assays per hour to identify small-molecule leads for mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases and cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanna Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tissue Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tissue Solutions
2.2 - Growth funds investing in similar companies to Tissue Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tissue Solutions
4.2 - Public trading comparable groups for Tissue Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →